Neudle.com: plasma exchange

Differential
(Click to cross reference)

abortion, spontaneous

acetylcholine receptor

acetylcholine receptor antibody

acute disseminated encephalomyelitis

ADAMTS 13

ADAMTS13 deficiency

advances in neurology

adverse drug reaction

agitation

algorithm

alpha-fetoprotein

altered states of consciousness

anti GQ1b IgG antibody

anti Hu antibody

anti Yo antibody

antibodies to voltage-gated calcium channels

anticholinesterase

anticoagulant, treatment

anticonvulsants

antiganglioside antibodies

antimetabolite

antiphospholipid antibody syndrome

antistriational muscle antibody

autonomic dysfunction

azathioprine

bacterial infection

bacterial infection, CNS

brachial plexus neuropathy

calcium channel dysfunction

campylobacter infection

CAT scan, emission, abnormal

cauda equina, lesion of

celiac disease, adult

cerebellar degeneration

cerebellitis

cerebral venous thrombosis

cerebrospinal fluid, abnormal

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, oligoclonal IgG in

cerebrovascular accident

cerebrovascular accident, young adult

cesarean section

chemotherapy, CNS treatment and complications with

Cheyne Stokes respirations

Clinical Pathologic Conference(C.P.C.)

contactin associated protein like 2 antibodies

controversies in neurology

cranial nerve palsies

cranial neuropathy, multiple

demyelinating disease

differential diagnosis

diphtheria

diplopia

disability, neurological

disorientation

distal muscle weakness

drug induced neurologic disorders

electroencephalogram, abnormalities of

electromyogram

electromyogram, decremental response

emergencies, medical

emergencies, neurologic

encephalitis

encephalitis, autoimmune

encephalitis, clinical picture and treatment of

encephalitis, focal

encephalitis, Rasmussen's

encephalomyelitis

encephalomyelitis, postinfectious

encephalopathy

endocarditis, marantic

entrapment neuropathy

epidemiology of neurology

episodic neurologic deficits

Epstein-Barr virus

evidence-based research

gammaglobulin therapy, intravenous

ganglionitis

gastroenteritis

gender

glutamic acid decarboxylase, antibody

GM1 ganglioside

GM1 ganglioside antibodies

Guillain Barre syndrome

Guillain Barre syndrome, axonal form

Guillain Barre syndrome, cardiovascular complications

Guillain Barre syndrome, complications

Guillain Barre syndrome, differential diagnosis of

Guillain Barre syndrome, etiology of

Guillain Barre syndrome, infantile and childhood form

Guillain Barre syndrome, prognosis of

Guillain Barre syndrome, relapse

Guillain Barre syndrome, variant forms of

hallucination

headache

hematuria, gross

hematuria, microscopic

hemiparesis

hemolysis

hemolytic-uremic syndrome

heparin

heparin, low-molecular-weight

heparin, subcutaneous

hepatomegaly

heralding manifestation

herpes simplex encephalitis, differential diagnosis of

Hodgkin's disease, neurologic involvement with

home management

hospital length of stay

hospitalization

human T-lymphotropic virus type I(HTLV-I)

hyponatremia with cerebral disorders

hyporeflexia

hypothyroidism

iatrogenic neurologic disorders

idiopathic thrombocytopenic purpura

imbalance

immune checkpoint inhibitors

immune reconstitution inflammatory syndrome

immune-related adverse events

immunologic disease

immunology and the nervous system

immunosuppression

immunosuppressive agents

immunotherapy

inappropriate antidiuretic(A.D.H.)hormone

inappropriate antidiuretic(A.D.H.)hormone, CNS involvement with

intracranial hypertension, benign

intracranial pressure, increased

intrinsic hand muscles, wasting of

lactic dehydrogenase(LDH)

leg weakness, bilateral

leucine rich glioma inactivated 1 antibodies

leukapheresis

leukoencephalitis, acute necrotizing hemorrhagic

level of consciousness, decreased

Lhermitte's sign

lid abnormalities

lid closure, weakness of

lid twitch

limbic encephalitis

limbic system

lipoprotein receptor-related protein 4

lymphoma involving CNS

magnesium sulfate

Mary Walker phenomenon

mediastinum, mass of

melanoma, malignant

memory, impairment of

meningeal enhancement

mental status, abnormal

mesial temporal lobe

mestinon

microangiopathic hemolytic anemia

microangiopathy, brain

microvascular thrombi

middle cerebral artery, occlusion of

misdiagnosis

monoclonal antibodies

monoclonal gammopathy

monoclonal gammopathy of uncertain significance

mononeuritis multiplex

mortality

Morvan's fibrillary chorea

movement disorder

movement disorder, treatment of

MRI

MRI, abnormal

MRI, contrast enhanced

MRI, disappearing lesion on

MRI, spinal cord, increased intramedullary cord signal

MRS

multiple organ failure

multiple sclerosis

multiple sclerosis, acute

multiple sclerosis, chronic progressive

multiple sclerosis, relapsing

multiple sclerosis, treatment of

multiple sclerosis, tumefactive

muscle weakness, proximal

MuSK antibodies

myasthenia gravis

myasthenia gravis, classification

myasthenia gravis, diagnosis

myasthenia gravis, differential diagnosis

myasthenia gravis, drug induced

myasthenia gravis, drug resistant

myasthenia gravis, etiology of

myasthenia gravis, exacerbation

myasthenia gravis, infantile and juvenile

myasthenia gravis, misdiagnosis of

myasthenia gravis, neonatal

myasthenia gravis, neuromuscular junction in

myasthenia gravis, ocular

myasthenia gravis, passive transfer of

myasthenia gravis, presenting manifestations

myasthenia gravis, prognosis of

myasthenia gravis, receptor site in

myasthenia gravis, remission of

myasthenia gravis, seronegative

myasthenia gravis, thymectomy in

myasthenia gravis, treatment of

myasthenia gravis, unmasked

myasthenia gravis, variants

myasthenic crisis

myasthenic syndrome

myasthenic syndrome, treatment of

mycophenolate

mycoplasma

mycoplasma pneumoniae

myelitis

myelitis, longitudinal

myelitis, transverse

myelitis, transverse, idiopathic

myelitis, transverse, prognosis

myelitis, transverse, recurrent

myelomalacia

myelopathy

myelopathy, chronic progressive

myocardial infarction

neoplastic angioendotheliosis

nephritis

nerve conduction studies

nerve hypertrophy

nerve root hypertrophy

neurologic complications of, systemic cancer

neurologic complications of, systemic disease

neurologic disease

neurologic disease, diagnoses of

neurologic examination, focal

neurologic signs

neurologic testing

neuromuscular disease, electrodiagnosis of

neuromuscular junction

neuromuscular junction, abnormality of

neuromyelitis optica (Devic's disease)

neuromyotonia

neuronopathy, sensory

neuroophthalmology

neuropathy

neuropathy, cryoglobulinemic

neuropathy, diabetic

neuropathy, diphtheritic

neuropathy, iatrogenic

neuropathy, motor, multifocal

neuropathy, painful

neuropathy, peripheral

neuropathy, peripheral, treatment

neuropathy, toxic

neuropathy, vasculitic, nonsystemic

obsessive-compulsive disorder

obstetric complications

ocular motility, disorders of

old age, neurology of

ophthalmoplegia

ophthalmoplegia, acute

ophthalmoplegia, bilateral, acute

ophthalmoplegia, total

opportunistic infection

opportunistic infection, CNS

opsoclonus

opsoclonus-myoclonus syndrome

optic nerve, enhancement

optic neuritis

optic neuritis, bilateral

optic neuritis, treatment of

pain

pain, abdominal

paraneoplastic cerebellar degeneration

paraparesis

paraproteinemia

parenteral alimentation

peripheral blood smear

peripheral blood smear, abnormal

personality change

placenta

plasmapheresis

plasmapheresis, complications of

platelet inhibiting drugs

platelet thrombi

pleocytosis of cerebrospinal fluid

pneumonia

polyclonal gammopathy

polymerase chain reaction

polymerase chain reaction, false negative

polymyositis

polyneuropathy

polyneuropathy, chronic inflammatory demyelinating

polyneuropathy, chronic inflammatory demyelinating, childhood

polyneuropathy, chronic inflammatory demyelinating, variant form

polyneuropathy, chronic inflammatory demyelinating-pure motor syn

polyneuropathy, chronic inflammatory demyelinating-sens atax var

polyneuropathy, chronic inflammatory demyelinating-variant forms

polyneuropathy, chronic relapsing

polyneuropathy, critically ill

position sensation

post infectious polyneuropathy

posterior column disease

postpartum

potassium channel antibodies

practice guidelines

preclinical

pregnancy, neurologic complications in

prognosis

progressive encephalomyelitis with rigidity syndrome

progressive multifocal leucoencephalopathy

progressive neurologic disorder

pseudointernuclear ophthalmoplegia

psychiatric problems in neurologic disorders

psychological testing

psychosis

ptosis

ptosis, bilateral

pulmonary function tests

pupil

pupil, abnormality in neurologic disorders

Purkinje cell

quality of life

quinine

radiation therapy, total body

rapidly progressing neurologic illness

remote effect of cancer on the nervous system

renal failure

renal failure, acute

renal infarct

renal vein thrombosis

repetitive nerve stimulation

respirator

respiratory failure

respiratory tract infection

retropulsion

retrovirus

reversible neurologic disorder

saccadic eye movements

saccadic eye movements, abnormal

safety

salivation, excessive

schistocytes

screening

sedimentation rate

sedimentation rate, elevated

seizure

seizure, intractable

seizure, medication failure

seizure, psychomotor-temporal lobe

sensory level

sensory loss

sensory loss, patchy

sensory nerve action potentials

septicemia

serologic testing

seronegative

sexual dysfunction in neurologic disease

single-fiber electromyography

sleep

sleep pathology and physiology

slurred speech

splenomegaly

staphylococcal protein A column therapy

steroid

steroid sparing therapy

steroid therapy, CNS treatment and complications with

stiff man syndrome

stillbirth

symmetric brain lesions

systemic illness

systemic lupus erythematosus

systemic lupus erythematosus, neurologic complications with

tacrolimus

tarsal tunnel syndrome

temporal lobe

temporal lobe, lesion

temporal lobe, lesion, bilateral

tensilon

tensilon test, false negative

tensilon test, false positive

tensilon test, paradoxical

thrombocytopenia

thrombophlebitis

thrombophlebitis, prophylaxis

thrombotic microangiopathy

thrombotic thrombocytopenia purpura

thymectomy

thymic hyperplasia

thymoma

thymus and neuromuscular function

thyroid function tests

transient ischemic attack

treatment of neurologic disorder

vibratory sensation, abnormal

weakness, generalized

weakness, progressive

Showing articles 100 to 150 of 277 << Previous Next >>

CIDP of Childhood:Treatment with High-Dose Intravenous Immunoglobulin
Neurol 41:828-830, Vedanarayanan,V.V.,et al, 1991

Acute Hemorrhagic Leukoencephalitis, A Successful Recovery
Arch Neurol 48:1086-1088, Seales,D.&Greer,M., 1991

The Role of Plasmapheresis in Childhood Guillain-Barre Syndrome
Ann Neurol 28:65-69, Epstein,M.A.&Sladky,J.T., 1990

Autoantibody Synthesis in the Central Nervous System of Patients with Paraneoplastic Syndromes
Neurol 40:1085-1091, Furneaux,H.F.,et al, 1990

Citrate-Induced Impairment of Neuromuscular Transmission in Human and Experimental Autoimmune Myasthenia Gravis
Ann Neurol 27:328-330, Wirguin,I.,et al, 1990

Epilepsy, Myasthenia Gravis, and Effect of Plasmapheresis on Antiepileptic Drug Concentrations
Arch Neurol 47:66-68, Lai,C.W.,et al, 1990

Double-Blind Study of True vs. Sham Plasma Exchange in Patients Treated with Immunosuppression for Acute Attacks of MS
Neurol 39:1143-1149, Weiner,H.L.,et al, 1989

Plasmapheresis in the Treatment of Stiff-Man Syndrome
NEJM 320:1499, Vicari,A.M.,et al, 1989

Immunotherapy of Multiple Sclerosis
Ann Neurol 23:211-223, Weiner,H.L.&Hafler,D.A., 1988

Limited Relapse in Guillain-Barre Syndrome after Plasma Exchange
Arch Neurol 45:314-315, Ropper,A.H.,et al, 1988

Plasmapheresis in Treatment of Human T-Lymphotropic Virus Type-I Associated Myelopathy
Lancet 2:1109-1113, Matsuo,H.,et al, 1988

Plasmapheresis and Guillain-Barre Syndrome:Analysis of Prognostic Factors & the Effect of Plasmapheresis
Ann Neurol 23:347-353, McKhann,G.M.,et al, 1988

Plasmapheresis for Myasthenic Crisis in a Young Child
J Pediatr 110:740-742, Snead,O.C.III.,et al, 1987

Efficiency of Plasma Exchange in Guillain-Barre Syndrome:Role of Replacement Fluids
French Cooperative Group, Ann Neurol 22:753-761, 762-763987., , 1987

Prediction of Early Beneficial Response to Plasma Exchange in Guillain-Barre Syndrome
Arch Neurol 44:295-298, Gruener,G.,et al, 1987

Guillain-Barre Syndrome:Quantitative Measurement of Plasma Exchange Therapy
Neurol 37:837-840, Farkkila,M.,et al, 1987

Plasma Exchange in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
NEJM 314:461-465, Dyck,P.J.,et al, 1986

The Eaton-Lambert (Myasthenic) Syndrome in Association with Systemic Lupus Erythematosus
Arch Neurol 43:1186-1187, Hughes,R.L.&Katirji,M.B., 1986

The Utility of Therapeutic Plasmapheresis for Neurological Disorders
JAMA 256:1333-1337, , 1986

Plasma Exchange & Prednisone in Guillain-Barre Syndrome:A Controlled Randomized Trial
Neurol 35:1551-1555, Mendell,J.R.,et al, 1985

An Assessment of Plasma Exchange in Progressive Multiple Sclerosis
Neurol 35:320-322, Weiner,H.L., 1985

Plasmapheresis & Acute Guillain-Barre Syndrome
The Guillain-Barre Syndrome Study Group, Neurol 35:1096-11041985., , 1985

Persistence of Antibrain Antibodies in Cerebrospinal Fluid During Plasmapheresis for Multiple Sclerosis
BMJ 291:850-851, Rybert,B.&Pirskanen,R., 1985

Chronic Long-Interval Plasma Exchange in Myasthenia Gravis
Arch Neurol 41:715-717, Rodnitzky,R.L.,et al, 1984

Beneficial Effects of Plasma Exchange in Acute Inflammatory Polyradiculoneuropathy
Lancet 2:1296-1298, & 131384., Osterman,P.O.,et al, 1984

Plasmapheresis Therapeutic or Experimental Procedure
Arch Neurol 41:647-653, Dau,P.C., 1984

Plasma Exchange in Neurologic Diseases
Arch Neurol 41:654-657, Lisak,R.P., 1984

Controlled Trial of Plasma Exchange in Acute Inflammatory Polyradiculoneuropathy
Lancet 1:877-879, Greenwood,R.J.,et al, 1984

Plasma Exchange & Immunosuppressive Drug Treatment in the Lambert-Eaton Myasthenic Syndrome
Neurol 34:480-485, Newsom-Davis,J.,et al, 1984

Lympocytapheresis in Chronic Progressive Multiple Sclerosis:Results of a Preliminary Trial
Ann Neurol 14:593-594, Rose,J.,et al, 1983

Neurological Deficit Associated with Mycoplasma Pneumoniae Reversed by Plasma Exchange
BMJ 286:22, Cotter,F.E., 1983

Tarsal Tunnel Syndrome Caused by Hyperlipidemia, Reversal After Plasmapheresis
Arch Neurol 40:124-125, Ruderman,M.I.,et al, 1983

Plasmapheresis & Immunosuppressive Drug Therapy in the Eaton-Lambert Syndrome
Ann Neurol 11:570-575, Da,P.C.,et al, 1982

The Pathogenesis of Cryoglobulinemic Neuropathy
Neurol 32:725-729, Chad,D.,et al, 1982

Severe Deafness in Systemic Lupus Erythematosus:Its Immediate Relief by Plasma Exchange
BMJ 284:1374, Hamblin,T.J.,et al, 1982

Complications of Plasma Exchange in Neurological Patients
Arch Neurol 39:350-354, Rodnitzky,R.L.,et al, 1982

Treatment of the Guillain-Barre Syndrome by Plasma Exchange
JNNP 45:847-850, Kennard,C.,et al, 1982

Plasmapheresis in the Treatment of Four Cases of Guillain-Barre Syndrome (acute form)
Ital. J Neurol Sci 4:331-3361981., Zerbi,D.,et al, 1981

Plasmapheresis in Idiopathic Inflammatory Myopathy Experience With 35 Patients
Arch Neurol 38:544-552, Dau,P.C., 1981

Successful Plasmapheresis in the Miller-Fisher Syndrome
BMJ 282:778, Littlewood,R.,et al, 1981

No Direct Correl. of Serum Ach Receptor Antib. Levels & Clin. State of Individual Patients with Myasthenia Gravis
Neurol 31:220-224, Roses,A.D.,et al, 1981

Plasmapheresis in Multiple Sclerosis:Preliminary Findings
Neurol 30:1023-1028, Dau,P.C.,et al, 1980

Plasma Exchange:Aid to Therapy of Multiple Sclerosis
Neurol 30:1111, vandenNoort,S.,et al, 1980

Plasmapheresis in Multiple Sclerosis:Preliminary Study
Neurol 30:1029-1033, Weiner,H.L.,et al, 1980

Guillain-Barre Syndrome:Is There a Role for Plasma-pheresis
Neurol 30:1112, Asbury,A.,et al, 1980

Controversies About the Treatment of Myasthenia Gravis
JNNP 43:644-659, Rowland,L.P., 1980

Treatment of Chronic Relapsing Inflammatory Polyradiculoneuropathy by Plasma Exchange
Ann Neurol 6:258-261, Server,A.C.,et al, 1979

Myasthenia Gravis
NEJM 298:136, Drachman,D.B., 1978

Function of Circulating Antibody to Acetylcholine Receptor in Myasthenia Gravis:Investigation by Plasma Exchange
Neurol 28:266, Newsom-Davis,J.,et al, 1978

Plasmapheresis & Immunosuppressive Drug Therapy in Myasthenia Gravis
NEJM 297:1134, Dau,P.C.,et al, 1977

Showing articles 100 to 150 of 277 << Previous Next >>